Literature DB >> 3040809

Angiotensin-converting enzyme labeled with [3H]captopril. Tissue localizations and changes in different models of hypertension in the rat.

S K Wilson, D R Lynch, S H Snyder.   

Abstract

In vitro autoradiography with [3H]captopril was used to localize and quantitate angiotensin-converting enzyme (ACE) in various tissues in two-kidney, one-clip (2K-1C) hypertension, one-kidney, one-clip (1K-1C) hypertension, desoxycorticosterone acetate (DOCA)-salt hypertension, and a normotensive control group. There were no significant differences in mean systolic blood pressure among the hypertensive groups. Plasma renin activity (PRA) was highest in the 2K-1C group (6.20 +/- 2.17 ng/ml per h), intermediate in the 1K-1C group (2.19 +/- 0.62 ng/ml per h) and control group (3.20 +/- 0.53 ng/ml per h), and lowest in the DOCA-salt group (0.07 +/- 0.06 ng/ml per h). In the lungs, aorta, mesenteric arteries, and adrenal medulla, ACE labeling was highest in the 2K-1C group, intermediate in the 1K-1C and control groups, and lowest in the DOCA-salt group. ACE levels in these tissues correlated positively with PRA. In the kidney, anterior pituitary, testis, and choroid plexus of the brain, ACE levels correlated negatively with PRA, with lowest ACE levels in the 2K-1C group and highest levels in the DOCA-salt group. In the epididymis, posterior pituitary, and other regions of the brain, ACE levels did not differ significantly among the groups.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040809      PMCID: PMC442311          DOI: 10.1172/JCI113142

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Production of hypertension with desoxycorticorticosterone acetate-impregnated silicone rubber implants.

Authors:  H S Ormsbee; C F Ryan
Journal:  J Pharm Sci       Date:  1973-02       Impact factor: 3.534

2.  Converting-enzyme in the choroid plexus, brain, and kidney: immunocytochemical and biochemical studies in rats.

Authors:  E Rix; D Ganten; B Schüll; T Unger; R Taugner
Journal:  Neurosci Lett       Date:  1981-03-10       Impact factor: 3.046

3.  Vascular renin-like activity and blood pressure maintenance in the rat. Studies of the effect of changes in sodium balance, hypertension and nephrectomy.

Authors:  H Thurston; J D Swales; R F Bing; B C Hurst; E S Marks
Journal:  Hypertension       Date:  1979 Nov-Dec       Impact factor: 10.190

4.  Effect of angiotensin II on in vivo and in vitro release of anterior pituitary hormones in the female rat.

Authors:  M K Steele; A Negro-Vilar; S M McCann
Journal:  Endocrinology       Date:  1981-09       Impact factor: 4.736

5.  Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence.

Authors:  U S Ryan; J W Ryan; C Whitaker; A Chiu
Journal:  Tissue Cell       Date:  1976       Impact factor: 2.466

6.  Angiotensin-converting enzyme: vascular endothelial localization.

Authors:  P R Caldwell; B C Seegal; K C Hsu; M Das; R L Soffer
Journal:  Science       Date:  1976-03-12       Impact factor: 47.728

7.  Renin release, an artifact of anesthesia and its implications in rats.

Authors:  W A Pettinger; K Tanaka; K Keeton; W B Campbell; S N Brooks
Journal:  Proc Soc Exp Biol Med       Date:  1975-03

8.  A simple microassay for the estimation of renin concentration in plasma.

Authors:  A Husain; C W Jones
Journal:  J Pharmacol Methods       Date:  1980-09

9.  Circadian changes in plasma renin activity and plasma aldosterone concentration in two-kidney hypertension rats.

Authors:  J M DeForrest; J O Davis; R H Freeman; G A Stephens; B E Watkins
Journal:  Hypertension       Date:  1979 Mar-Apr       Impact factor: 10.190

10.  Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.

Authors:  H Thurston; J D Swales
Journal:  Clin Sci Mol Med       Date:  1977-03
View more
  6 in total

Review 1.  Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.

Authors:  Lijun Shi; Caiping Mao; Zhice Xu; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-02-17       Impact factor: 7.851

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

3.  Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.

Authors:  A Zerrouk; M Auguet; S Delaflotte; P E Chabrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

4.  Effect of samarium oxide nanoparticles on virulence factors and motility of multi-drug resistant Pseudomonas aeruginosa.

Authors:  Hossein Zahmatkesh; Mirsasan Mirpour; Hojjatolah Zamani; Behnam Rasti; Fatemeh Asadi Rahmani; Nasim Padasht
Journal:  World J Microbiol Biotechnol       Date:  2022-08-30       Impact factor: 4.253

Review 5.  Novel molecular angiotensin converting enzyme and angiotensin receptor imaging techniques.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

Review 6.  Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics.

Authors:  G S Thind
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.